Patient subgroup analyses of the treatment effect of subcutaneous interferon β-1a on development of multiple sclerosis in the randomized controlled REFLEX study

The REFLEX study (NCT00404352) established that subcutaneous (sc) interferon (IFN) β-1a reduced the risks of McDonald MS (2005 criteria) and clinically definite multiple sclerosis (CDMS) in patients with a first clinical demyelinating event suggestive of MS. The aim of this subgroup analysis was to...

Descripción completa

Detalles Bibliográficos
Autores principales: Freedman, Mark S., De Stefano, Nicola, Barkhof, Frederik, Polman, Chris H., Comi, Giancarlo, Uitdehaag, Bernard M. J., Casset-Semanaz, Florence, Hennessy, Brian, Lehr, Lorenz, Stubinski, Bettina, Jack, Dominic L., Kappos, Ludwig
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2014
Materias:
Original Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3948518/
https://www.ncbi.nlm.nih.gov/pubmed/24413638
http://dx.doi.org/10.1007/s00415-013-7222-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3948518/
https://www.ncbi.nlm.nih.gov/pubmed/24413638
http://dx.doi.org/10.1007/s00415-013-7222-6

Ejemplares similares